Along with our clinical analysis (Figure 4), these results suggest that NSCLC cells expressing high levels of Id1 may show a preference to rely on Id1 for survival (i.e. addiction to Id1), and therefore targeting Id1 in NSCLC cells with high Id1 expression would be considered a potentially effective therapeutic strategy. Here, ID1 is linked to non-small cell lung carcinoma.